Global Atorvastatin Calcium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- SKU ID : GIR-GIR1901260497 13772614
- |
- Publishing Date: 18-Mar-2019
- |
- Region: Global
- |
- No. of pages: 138
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Scope of the Report:
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
The worldwide market for Atorvastatin Calcium is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 230 million US$ in 2024, from 160 million US$ in 2019, according to a new study.
This report focuses on the Atorvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemical Synthesis
Biocatalysis
Others
Market Segment by Applications, can be divided into
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atorvastatin Calcium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Atorvastatin Calcium, with price, sales, revenue and global market share of Atorvastatin Calcium in 2017 and 2018.
Chapter 3, the Atorvastatin Calcium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atorvastatin Calcium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Atorvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Atorvastatin Calcium sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
The worldwide market for Atorvastatin Calcium is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 230 million US$ in 2024, from 160 million US$ in 2019, according to a new study.
This report focuses on the Atorvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemical Synthesis
Biocatalysis
Others
Market Segment by Applications, can be divided into
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atorvastatin Calcium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Atorvastatin Calcium, with price, sales, revenue and global market share of Atorvastatin Calcium in 2017 and 2018.
Chapter 3, the Atorvastatin Calcium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atorvastatin Calcium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Atorvastatin Calcium market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Atorvastatin Calcium sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
